Systemic and coronary hemodynamic effects of glucagon.
D000818:Animals; D001158:Arteries / Q000187:drug effects; D001786:Blood Glucose / Q000032:analysis; D001794:Blood Pressure / Q000187:drug effects; D006328:Cardiac Catheterization; D002302:Cardiac Output / Q000187:drug effects; D003331:Coronary Vessels / Q000187:drug effects*; D004285:Dogs; D005934:Glucagon / Q000494:pharmacology*; D006339:Heart Rate / Q000187:drug effects; D006400:Hematocrit; D006439:Hemodynamics / Q000187:drug effects*; D006454:Hemoglobins / Q000032:analysis; D007773:Lactates / Q000097:blood; D009206:Myocardium / Q000378:metabolism; D010100:Oxygen / Q000097:blood; D010101:Oxygen Consumption / Q000187:drug effects; D011433:Propranolol / Q000494:pharmacology; D011773:Pyruvates / Q000097:blood; D012039:Regional Blood Flow; D014655:Vascular Resistance / Q000187:drug effects
D001786:Blood Glucose; D006454:Hemoglobins; D007773:Lactates; D011773:Pyruvates; D005934:Glucagon; D011433:Propranolol; D010100:Oxygen